SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹4,082 Cr | ₹1,870 Cr | ₹2,846 Cr | ₹6,198 Cr | ₹931 Cr |
What is the latest Total Debt ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹4,082 Cr |
| Mar2025 | ₹1,870 Cr |
| Mar2024 | ₹2,846 Cr |
| Mar2023 | ₹6,198 Cr |
| Mar2022 | ₹931 Cr |
How is Total Debt of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,082 Cr | 118.31 | |
| Mar2025 | ₹1,870 Cr | -34.30 | |
| Mar2024 | ₹2,846 Cr | -54.09 | |
| Mar2023 | ₹6,198 Cr | 565.94 | |
| Mar2022 | ₹931 Cr | - | |
Compare Total Debt of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,464.2 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
| MANKIND PHARMA | ₹100,152.0 Cr | -1.1% | -3.4% | -7.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -0.5% |
0.8% |
19% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses